RecruitingEarly Phase 1NCT05377216

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

Sponsor

University of Pennsylvania

Enrollment

20 participants

Start Date

Sep 1, 2022

Study Type

INTERVENTIONAL

Conditions

Ventricular Tachycardia

Summary

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Planned catheter based VT ablation
Age at least 18 years

Exclusion Criteria4

Pregnancy
Contraindication to SGB or VT ablation
Hypersensitivity of local anesthetic of amide type
Hemodynamic instability during the procedure prior to the study protocol

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGStellate Ganglion Block

Left sided percutaneous stellate ganglion block

Locations(1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05377216

Related Trials

International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction

NCT062940281 location